The 4th generation synchrotron source MAX IV welcomes  beamtime proposals for 
BioMAX, FragMAX, MicroMAX and CoSAXS. 

BioMAX and MicroMAX are dedicated macromolecular  crystallography beamlines. 
BioMAX is capable of a wide array of techniques, from high throughput 
conventional oscillation experiments to serial crystallography. BioMAX also 
hosts FragMAX, a fragment-based drug discovery platform.
MicroMAX is ideally suited for microfocus applications, serial crystallography 
and time-resolved experiments. In this call MicroMAX is open for automated 
high-throughput crystallography. Please contact the staff for commissioning 
experiments in the area  of serial crystallography and time-resolved 
experiments. 
The CoSAXS beamline is a state-of-the-art multipurpose Small Angle X-ray 
Scattering  (SAXS) instrument offering protein solution and time resolved SAXS 
amongst other techniques. 

Proposal application deadline:  September 25th  2023 23:59 CET

Beamtime period: Mar 2024 - Aug 2024

Proposal submission: 
https://www.maxiv.lu.se/user-access/user-guide/proposal-submission/

BioMAX:
https://www.maxiv.lu.se/beamlines-accelerators/beamlines/biomax/

FragMAX:
https://www.maxiv.lu.se/beamlines-accelerators/science-initiatives/fragmax-biomax-fragment-screening-platform/

MicroMAX:
https://www.maxiv.lu.se/beamlines-accelerators/beamlines/micromax/

CoSAXS:
https://www.maxiv.lu.se/beamlines-accelerators/beamlines/cosaxs/

Contacts:
Ana Gonzalez ana.gonza...@maxiv.lu.se  (BioMAX)
Tobias Krojer tobias.kro...@maxiv.lu.se  (FragMAX)
Thomas Ursby thomas.ur...@maxiv.lu.se  (MicroMAX) 
Ann Terry ann.te...@maxiv.lu.se  (CoSAXS)  
 

    
########################################################################

To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1

This message was issued to members of www.jiscmail.ac.uk/CCP4BB, a mailing list 
hosted by www.jiscmail.ac.uk, terms & conditions are available at 
https://www.jiscmail.ac.uk/policyandsecurity/

Reply via email to